Topics › Drug Policy
Commentary by Michelle Minton
Psychedelics Policy Newsletter by Gregory Ferenstein
Commentary by Gregory Ferenstein
Commentary by Jacob James Rich
Policy Study by Jacob James Rich and Robert Capodilupo
Commentary by Geoffrey Lawrence
Policy Brief by Nathan Daigneault
Testimony by Leonard Gilroy and Geoffrey Lawrence